In rare cases, patients with Gitelman syndrome may present with hypokalemic paralysis mimicking Guillain-Barré syndrome. The severity of resultant symptoms may be life-threatening. Controversial drugs such as aldactone, amiloride, and eplerenone should be used in this situation despite the lack of safety data.
Keywords: Controversial drugs; Gitelman syndrome; Guillain–Barré syndrome; hypokalemic paralysis; outcome; pregnancy.